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The Rho family GTPases are small molecular weight gunanine nucleotide-binding 
proteins that belong to the Ras superfamily of GTPases. Their importance became clear 
about a decade ago when they were first shown to regulate actin cytoskeleton 
rearrangements in mouse fibroblasts. Since then about twenty members of the Rho 
family have been identified, with RhoA, Racl and Cdc42 being the best characterized. 
RhoA induces the formation of actin stress fibers and focal adhesions, Rac and Cdc42 
proteins regulate lamellipodia and filopodia formation, respectively. In our days it is 
apparent that they are not only involved in organizing cytoskeletal changes in cells but 
also involved in the regulation of many other processes, like Gi progression of the cell 
cycle, cell proliferation, DNA synthesis, transcription factor activation and activation of 
the P67NADPH-oxidase in neutrophil granulocytes, just to mention a few. Rho GTPase 
proteins are highly conserved molecules, sharing about 50-90 % sequence similarity 
within the family and about 30-50 % similarity to other Ras GTPase proteins. Similarly 
to Ras proteins, Rho GTPases are post-translationally modified at their C-terminus 
(CAAX sequence), acquiring an isoprenoid lipid tail which is important in directing 
them to the plasma membrane.
Rho GTPase proteins exist either in an active GTP-bound or in an inactive GDP- 
bound state. Alter stimulation by upstream signals, GDP-bound Rho GTPases release 
GDP and bind GTP. In the GTP-bound active state Rho proteins recognize and activate 
their specific effector targets and induce downstream molecular events. They posses 
GTPase activity which hydrolyzes GTP to GDP, returning the GTPase to the inactive 
state. The inactivation of GTPases leads to the release and inactivation of the bound 
effectors. There are two groups of proteins that interact with Rho family GTPases to 
regulate the GDP/GTP binding cyle: (i) the Dbl family proteins that are Rho GTPase 
specific guanine nucleotide exchange factors (Rho GEFs), and (ii) the Rho GTPase 
activating proteins (Rho GAPs). The former greatly enhance the GDP/GTP exchange 
rate by stimulating GDP dissociation from and facilitating GTP binding to Rho 
GTPases, the latter accelerate the GTPase activity. It has been increasingly accepted 
that the spatial and temporal control of the GTP-binding/GTP-hydrolysis cycle of Rho 
GTPases is essential for their proper function in cells.
The Dbl family GEFs are large multidomain proteins that contain at least one DH- 
PH domain unit, where the PH domain is invariably located immediately C-terminal to
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the DH domain. While the DH domain alone is able to facilitate the exchange of bound' 
GDP for GTP in vitro on Rho proteins, the DH-PH unit is necessary for their activity in 
vivo. In the past few years a large number of Dbl family members have been 
discovered. Except for the DH-PH module, these proteins are very diverse in their 
stucture and size. In addition to the conserved PH-DH domain they contain different 
domains that vary in the different Rho-GEFs. Little is known about their exact role, but 
probaly they regulate the activity of the GEFs and provide connections to upstream 
activators. Since many Dbl family proteins may exert potent protooncogenic effects, 
their activity must be strictly regulated in cells under normal conditions. Before 
stimulation the inactivity of Dbl proteins is maintained by different mechanisms in cells: 
By intramolecular interactions between the PH and the DH domains, or by interactions 
between the DH or PH domain and a regulatory domain. Oligomerisation through the 
DH domains and binding to specific inhibitory factors also helps to keep them in a 
minimum activity state. Numerous upstream signals can attenuate the negative 
regulation and stimulate the GEF activity. These include signals originating from G 
protein coupled receptors, cytokine receptors, growth factor receptors etc. Activated 
Ras protein, a» and py subunits of heterotrimeric G proteins and phosphatidylinositol 
3,4,5-trisphosphate were shown to bind directly to certain Dbl proteins and increase 
their activity. However the the detailed mechanisms of the activation of Dbl proteins 
and how they facilitate the GDP/GTP exchange on Rho proteins is still not clear.
Objectives
The three-dimensional structures of the DH domain of the Dbl family members p- 
P1X, Sos and the N-terminus of Trio have been resolved. The tertiary structures are 
remarkably similar among the three DH domains, all depicting a flattened, elongated a- 
helix bundle in which two of the three conserved regions, conserved region 1 (CR1) and 
conserved region 3 (CR3) are exposed near the center of one surface. Sequence analysis 
and limited mutagenesis studies suggest that several conserved residues in these regions 
may be involved in the formation of a Rho GTPase-interacting pocket. However, what 
biochemical function these residues exert in the nucleotide exchange reaction 
(nucleotide exchange versus Rho protein binding) and to what extent these sites 
contribute to the GEF-Rho protein interaction have not been assessed. To identify 
specific sites of the DH domain contributing to the nucleotide exchange or binding
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activity for Rho GTPases, we have characterized a large panel of DH mutants of 
oncogenic Dbl in vitro. The results help define specific roles of individual residues of 
the DH domain in the GEF reaction and binding activity.
Dominant negative mutants of Rho GTPases (such as T17NRacl or T17NCdc42) 
are widely in use to elucidate the role of individual Rho proteins in different signaling 
pathways. The proposed mechanism of the dominant negative mutant function is that 
they bind to their respective GEFs with high affinity and may sequester the endogenous 
Rho GEFs by forming non-fimctional dominant negative Rho protein-GEF complexes.
It is often assumed by users of these mutants that a given mutant blocks only the specific 
pathway that is activated by its wild type counterpart. Given the recent realization that 
many Dbl family GEFs, particularly the core DH-PH module which is responsible for 
Rho GTPase recognition and nucleotide exchange, are promiscuous in nature, it could 
be expected that overexpression of one dominant negative Rho GTPase, (typically two 
to three folds over the endogenous protein to be effective), might indiscriminatively 
inhibit other Rho GTPase activities by sequestering multiple GEFs or one GEF that is 
capable of activating multiple Rho proteins, leading to incorrect conclusions. In our 
experiments we have examined the specificity issue of dominant negative Rho proteins. 
We show that dominant negative Racl (T17NRacl) could indeed cause nonspecific 
inhibition of RhoA activity in an onco-Dbl transfected cell system.
Based on our findings with the Dbl mutant N673A/D674A and T17NRacl we 
have constructed a DH domain mutant of the Rac specific GEF, the N-terminal DH-PH 
module of Trio (TrioN), to examine the catalytic mechanism of Dbl family GEFs, and 
investigate whether mutants of certain substrate-specific Dbl-family GEFs can be used 
to specifically block their corresponding Rho GTPase-mediated signaling pathways.
We show, that a conserved pair of amino acid residues, Asnl406Trio-Asp65Racl of the 
TrioN-Rac 1 complex is essential for the GEF elicited nucleotide exchange of Rac 1, and 
present evidence that a TrioN mutant, N 1406A/D 1407A, behaves as a dominant 
negative inhibitor to specifically block Racl activation in vitro and in vivo. Our results 
indicate that dominant negative mutant derived from a Rho GTPase regulator constitutes 
a new generation of specific inhibitor of Rho GTPase signaling pathways.
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Materials and Methods
Generation of mutant Rho GEF cDNA constructs
The DH domain point mutants of Dbl and TrioN were generated by polymerase 
chain reaction (PCR) using primers that contained the desired mutations. The DNA 
fragments encoding the mutants were subsequently subcloned into pVL1392, pZipneo, 
pKH3, pMX-IRES-GFP or pCEFL-GST vectors. The sequences of mutagenized cDNA 
inserts were confirmed by automated DNA sequencing.
Expression of recombinant proteins
GST-fused small GTP-binding proteins or the (His)6-tagged TrioN proteins were 
expressed in and purified from pGEX or pET15b vector-transformed E. coli. GST-Dbl 
and DH mutants were produced in and purified from Sf9 insect cells. The concentration 
and integrity of purified proteins were estimated by the Bradford assay and Coomassie 
Blue-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
using serum albumin as a standard.
In vitro GDP/GTP exchange assay
The time courses for [3H]GDP/GTP exchange of Rho family GTPases (Cdc42, 
Racl orD65ARacl) in the presence or absence of the exchange factors (Dbl, Dbl 
mutants, TrioN or TrioN mutants) were determined by using the [5H]GDP-binding 
nitrocellulose filtration method or by monitoring the fluorescence changes caused by 
nucleotide analog mant-GDP dissociation from Racl.
Complex formation assay
HA-Dbl, Dbl DH mutants, (His)6-tagged TrioN or TrioN mutants were incubated 
with agarose-immobilized GST-fused dominant negative Rho GTPases (T17NCdc42, 
T17NRacl or T19NRhoA). The washed precipitates from the mixtures were subjected 
to 10 % SDS-PAGE and transferred to nitrocellulose for Western Wot analysis using 
anti-(His)6 (Boehringer-Mannheim) or anti-HA (Roche Molecular Biochemicals) 
antibody.
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Expression of TrioN and dominant negative Racl and Cdc42 mutants in cells '
Wild type, N1406A/D1407A and T1244A of TrioN, T17NRacl and T17NCdc42 
were expressed in NIH 3T3 or Swiss 3T3 cells by using the pMX-IRES-GFP vector. 
Retroviral packaging and infection were carried out as follows: Ecotropic Phoenix cells 
were transfected with individual retroviral vector and the retroviruses were harvested 48 
hrs post-transfection. The fibroblasts were infected with the retroviruses and cells were 
harvested 72 hrs post infection. GFP positive cells were sorted by fluorescence 
activated cell sorting (FACS) and were used for analysis immediately afier sorting.
In vivo GTPase activation assay
Glutathione agarose-immobilized GST-PAK1 and GST-Rhotekin were expressed 
and purified in E. coli by using the pGEX-KG vector. Lysates of NIH 3T3 cells 
containing equal amount of total proteins were incubated with GST, GST-PAK1, or 
GST-Rhotekin. The lysate-incubated beads were washed, and the bound Racl or RhoA 
were detected by anti-Racl or RhoA antibody (Santa Cruz Biotechnology).
Fluorescence microscopy
Log phase growing fibroblasts were seeded on round coverslips (Fisher Scientific) 
overnight before fixation and permeabilization. The cells were stained for F-actin using 
rhodamine conjugated phalloidin (Molecular Probes). Stained cells were analyzed by 
using a Zeiss confocal fluorescence microscope.
Transient luciferase reporter assay
For determination of serum response factor (SRF)-dependent gene expression, the 
SRF-luciferase reporter plasmid (Stratagene) that contains the promoter response 
elements of SRF was used in transient co-transfections with the pCEFL vector or 
pCEFL-N1406A/D1407A in the presence or absence of the wild type TrioN cDNA in 
pKH3 vector. Analysis of luciferase expression in the co-transfected NIH3T3 cells was 
carried out by using a luciferase assay kit from Promega.
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DNA synthesis assay
DNA synthesis was monitored by measuring incorporation of the artificial 
thymidine nucleotide analog 5-bromo-2'-deoxyuridine (BrdU) (Sigma) into newly 
synthesized DNA. BrdU (10 fiM) was added to the medium with 10 % serum or PDGF 
(10 nM), and 16 hrs later the cells were fixed and stained with anti-BrdU antibody (BD 
Biosciences).
Soft agar growth assay
NIH 3T3 cells expressing GFP, onco-Dbl together with GFP, onco-Dbl with GFP 
and TrioN mutant N1406A/D1407A, T17NRacl or T17NCdc42, were assayed for their 
capability to grow in soft agar. Cells were suspended in DMEM medium supplemented 
with 10 % calf serum and 0.3% agarose. Two and a halfweek post-plating, colonies 
larger than 50 pm were scored under a microscope.
Results
Analysis of the DH domain point mutants of Dbl
To examine the biochemical roles of the residues in the DH domain and to assess 
the contribution of individual residues to DH function in a biological setting, we have 
generated 19 alanine substitution mutations of the DH domain at CR1, CR3, and 
surrounding regions in the DH-PH backbone of oncogenic Dbl, based upon the 
structural predictions. Of the four CR1 and five CR3 region mutants examined, five 
displayed significant loss of GEF activity toward Cdc42 in the in vitro GDP/GTP 
exchange assay. The T506A mutation of CR1 caused the most severe effect, whereas 
L640A, where the leucine resides in the N terminus of hydrophobic LLLKELL 
sequences of CR3, appeared to retain only a fraction of the Cdc42 activation potential. 
Mutation of the charged residues Glu502, Gln633, and Arg634 also led to partial but 
significant loss of GEF activity, whereas the neighboring charged residues Gln505, 
Arg508, Lys630, or Lys643-Glu644 did not seem to directly participate in the GEF 
reaction because mutations of these residues had no detectable effect. Asn673-Asp674 
of the junction site with the PH domain appeared to be important because alanine 
substitution at these residues resulted in partial or complete loss of GEF function.
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Together with those mutations that do not affect the exchange capability on Cdc42, 
which help exclude the involvement of parts of a2, a6, loop 7, and a8, the results of the 
loss of function mutations point to a GTPase interaction surface along the shallow 
groove formed by the N-terminus of al and the middle section of a9, extending to part 
of a6 and the DH-PH junction. In the binding activity test E502A and Q633A retained 
most of their binding activities to both Cdc42 and RhoA, whereas T506A and R634A 
were inactive in binding to either GTPase. The functionally inactive N673A/D674A 
mutant retained almost the wild type binding activity to both Cdc42 and RhoA. We 
conclude from these data that residues Glu502, Gln633, and Asn673-Asp674 are mostly 
involved in the GDP/GTP exchange of the GEF reaction, whereas residues Thr506 and 
Arg634 may be responsible for the binding interaction with the GTPases. Furthermore 
the mutants E502A, Q633A, and N673A/D674A that showed no GDP/GTP exchange 
activity but remained capable of binding to Cdc42 and RhoA were unable to activate the 
small G-proteins in cells, suggesting that the guanine nucleotide exchange activity of 
Dbl is required for Rho GTPase activation in vivo.
T17NRacl non-specifically inhibits the Rho pathway
To address the possibility that expression of one type of dominant negative Rho 
protein may unbalance the activity of distinct Rho family members by sequestering a 
commonly shared GEF, we transduced T17NRacl or T17NCdc42 into NIH 3T3 cells 
expressing oncogenic Dbl protein (Dbl cells) and examined the effects on the cells* actin 
structure and endogenous Racl and RhoA activities. The cells expressing Dbl showed a 
more compact cell shape, and filament actin staining revealed extensive lamellipodia 
formation along the cell edges and the retaining stress fibers in the cells in accordance 
with the previous findings that Dbl can bind to and activate multiple Rho proteins 
including Racl and RhoA. Effector domain pull-down assays showed that the levels of 
the GTP-bound Racl and RhoA were significantly enhanced in the Dbl expressing cells 
compared with the parental cells. When T17NRacl or T17NCdc42 was coexpressed in 
the Dbl expressing cells, it appeared that either protein could inhibit the lamellipodia 
and actin stress fiber formation. Moreover, they effectively suppressed both 
endogenous Racl and RhoA activities that were upregulated by onco-Dbl. These results 
indicate that the conventional dominant negative mutants of Rho GTPases may function
9
) )
non-specifically to inhibit distinct Rho GTPase activities by sequestering Dbl-like GEFs 
that are promiscuous in substrate recognition.
A$nl406-Asp65 pairing of TrioN-Racl is critical for GDP/GTP exchange
We rationalized that if substrate-specific GEF mutants that preserve specific Rho 
GTPase binding without nucleotide exchange activity could be engineered, they might 
act dominant negatively by inhibiting individual Rho GTPases and could be explored to 
specifically downregulate Rho GTPase-mediated signaling. Therefore, based on our 
results with the N673A/D674A mutant of Dbl and crystallographic data, we have 
constructed point mutants of the Racl specific N-terminal DH-PH module of Triol 
(TrioN), hoping to derive a TrioN mutant that could act dominant negatively on Rac 1. 
We produced N1406A/D1407A and T1244A mutants of TrioN as well as wild type 
TrioN as (His)«-tagged fusion proteins and tested their GDP/GTP exchange and Rho 
protein binding activities on Racl by reconstituting the purified components. The 
T 1244A mutant remained partially active in stimulating GDP dissociation from Racl, 
while N1406A/D1407A had lost the exchange activity completely in vitro. Mutation of 
the pairing Asp65 residue of Racl to Ala also lead to the loss of responsiveness of Racl 
to TrioN stimulation, indicating that the Asnl406-Asp65 pairing of TrioN and Racl 
interaction serves as critical structural determinant responsible for the GDP/GTP 
exchange. Furthermore, N1406A/D1407A was also able to inhibit the wild type TrioN- 
stimulated GDP release from Racl; this inhibitory effect was dose dependent, indicating 
that the mutant can indeed inhibit Racl activation albeit effective only at concentrations 
higher than wild type TrioN.
The N1406A/D1407A mutant of TrioN acts dominant negatively for Racl 
activation in vivo
To analyze the in vivo behavior of the mutant, we tested its effects on cell 
morphology and actin cytoskeleton in Swiss 3T3 cells. F-actin staining of the cells 
expressing wild type TrioN, one of the TrioN mutants or T17NRacl revealed that under 
serum-free conditions both wild type TrioN and T1244A induced peripheral 
lamefiipodia structures, whereas N1406A/D1407A caused a change of actin structure 
similar to T17NRacl. Upon stimulation with PDGF, an effective Racl pathway
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activator, the control cells readily produced lamellipodia extensions and the TrioN- and 
T1244A-expressing cells displayed further enhancement of their lamellipodia structures. 
In contrast, N1406A/D1407A readily inhibited the formation of lamellipodia induced by 
PDGF but retained actin stress fibers of the cells, whereas T17NRacl yielded a similar 
effect on lamellipodia but also eliminated actin stress fibers simultaneously. These 
results indicate thatN1406A/D1407A can act dominant negatively to inhibit Racl- 
mediated actin reorganization. Furthermore transfection of cDNA of the 
N1406A/D1407A mutant into the cells inhibited the activation of the serum response 
factor elicited by wild type TrioN. Upon examination of the N1406A/D1407A- 
expressing Dbl cells, we found that in contrast to T17NRacl, expression of this TrioN 
mutant maintained the enhanced actin stress fibers but induced a contracted cell body 
and disappearance of lamellipodia, suggesting that this mutant can distinguish Racl 
from RhoA activity. Further effector pulldown assays showed that N1406A/D1407A 
specifically inhibited Racl activity without affecting RhoA in the Dbl-cells.
The N1406A/D1407A mutant of TrioN can distinguish Racl from RhoA in cells
To demonstrate the advantage of the TrioN mutant over the dominant negative 
T17NRacl mutant, we next compared the effects of these mutants in two cellular 
functions: in PDGF-induced DNA synthesis and Dbl-induced cell transformation. We 
observed that in the control cells serum starvation led to a low basal DNA synthesis 
activity that could be significantly stimulated by PDGF, serum, wild type TrioN or the 
T1244A mutant of TrioN. Whereas T17NRacl effectively blocked the PDGF-elicited 
DNA synthesis but had no effect on the serum-induced activity, N1406A/D1407A did 
not alter the PDGF-induced BrdU incorporation despite of its significant impact on 
PDGF-induced actin structure of the cells. The N1406A/D1407A mutant that inhibited 
endogenous Racl activity did not affect anchorage-independent growth of the Dbl cells, 
contrary to the marked inhibitory effect of T17NRacl or T17NCdc42. These results 
further highlight potential complications of the use of conventional dominant negative 
Rho protein mutants, and suggest that dominant negative mutant derived from regulators 
of specific Rho family members such as Trio is better suited for the dissection of 
specific Rho GTPase signaling pathways.
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Conclusions
The Dbl related GEFs for Rho GTPases form a fast expanding cell growth 
regulatory protein family that is expected to play an important role in Rho GTPase 
regulation in diverse physiological systems. A large body of biochemical data has 
pointed to the conserved structural motif of this family, the DH domain, as the primary 
interactive site with Rho GTPases. In the present studies we have attempted to identify 
specific residues of DH domain that are critical for defined biochemical activities, i.e. 
the nucleotide exchange or the binding activities for Rho GTPases. The systematic 
alanine substitution approach in the postulated GTPase interactive surface of DH 
domain has allowed us to identify a panel of DH mutants made in the a l, a6, and a9 
regions and the PH junction site that suffer complete or partial loss of GEF activity 
toward Cdc42 and RhoA, suggesting that the mutation sites are required for the GEF 
function. The lack of effect by mutations in parts of a2, a6, loop 7, and a8, on the other 
hand, helped exclude the involvement of these regions. Our results provide strong 
support of a GTPase interaction surface of DH domain along the shallow groove formed 
by the N-terminus of a l and the middle section of a9, extending to a part of a6 and the 
DH-PH junction.
Dominant negative mutants of Rho GTPases, such as T19NRhoA, T17NRacl and 
T17NCdc42, have been widely in use to elucidate signaling pathways in different cell 
biological systems. Since many Dbl family GEFs shows promiscuity in binding activity 
towards multiple Rho GTPases it seems logical to expect that dominant negative Rho 
proteins may have non-specific effects when applied to sophisticated cellular systems by 
overexpression. Indeed, or results clearly demonstrate that T 1 TNRac 1, as well as 
T17NCdc42, can block the actin reorganization and biochemical activities of both Racl 
and RhoA in Dbl cells. The effects are consistent with the explanation that these 
mutants may titrate out the Rho protein activator, Dbl, by sequestering it in an activation 
deficient dominant negative Rho GTPase-Dbl complex. Therefore it is necessary to 
raise concerns to a body of literature in which non-selective use of dominant negative 
Rho protein mutants was solely dependent upon to implicate the involvement of specific 
Rho family members in complex cell signaling networks.
We have also examined the role of two most conserved residues of the TrioN GEF 
module, Thil244 that is located in the CR1 region and Asnl406 that is located close to 
the C-terminus of the DH domain. The results implicate Asnl406 of TrioN as the
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critical determinant in the GEF catalytic reaction of Rac 1. We propose that the highly 
conserved asparagine residue found in all Dbl family GEFs plays a parallel role in 
catalyzing Rho GTPase exchange as the famed "arginine finger" found in the Rho GAP 
catalytic reactions or the glutamic acid residue found in the Sec7 domain in catalyzing 
the guanine nucleotide exchange of ARF family small G-proteins.
The discovery of the key mechanistic role of Asnl406 of TrioN provided a 
valuable clue that mutant generated from this residue might behave in a dominant 
negative manner in inhibiting Rac-mediated signaling pathways. Indeed, our results 
indicate that N1406A/D1407A mutant of TrioN constitutes a dominant negative 
inhibitor of Rac-signaling pathways. Furthermore the results strongly suggest that 
N1406A/D1407A acts more specifically in blocking Rac-mediated signaling events than 
T17NRacl. Our results indicate that a dominant negative Rho GEF such as 
N1406ATrioN can serve as an alternative to dominant negative Rho GTPases for the 
dissection of sophisticated signal transmitting pathways through individual Rho 
proteins.
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